Discovery of MK-4409, a Novel Oxazole FAAH Inhibitor for the Treatment of Inflammatory and Neuropathic Pain

[Image: see text] We report herein the identification of MK-4409, a potent and selective fatty acid amide hydrolase (FAAH) inhibitor. Starting from a high throughput screening (HTS) hit, medicinal chemistry efforts focused on optimizing of FAAH inhibition in vitro potency, improving the pharmacokine...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Chobanian, Harry R., Guo, Yan, Liu, Ping, Chioda, Marc D., Fung, Selena, Lanza, Thomas J., Chang, Linda, Bakshi, Raman K., Dellureficio, James P., Hong, Qingmei, McLaughlin, Mark, Belyk, Kevin M., Krska, Shane W., Makarewicz, Amanda K., Martel, Elliot J., Leone, Joseph F., Frey, Lisa, Karanam, Bindhu, Madeira, Maria, Alvaro, Raul, Shuman, Joyce, Salituro, Gino, Terebetski, Jenna L., Jochnowitz, Nina, Mistry, Shruti, McGowan, Erin, Hajdu, Richard, Rosenbach, Mark, Abbadie, Catherine, Alexander, Jessica P., Shiao, Lin-Lin, Sullivan, Kathleen M., Nargund, Ravi P., Wyvratt, Matthew J., Lin, Linus S., DeVita, Robert J.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Chemical Society 2014
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4060928/
https://ncbi.nlm.nih.gov/pubmed/24944750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml5001239
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky